3 research outputs found
Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis
This study aims to provide practical recommendations on prophylaxis for infection in pediatric patients with immune-mediated rheumatic diseases receiving/scheduled to receive immunosuppressive therapy. A qualitative approach was applied. A narrative literature review was performed via Medline. Primary searches were conducted using MeSH terms and free text to identify articles that analyzed data on infections and vaccinations in pediatric patients with immune-mediated rheumatic diseases receiving immunosuppressive therapy. The results were presented and discussed in a nominal group meeting comprising a committee of 12 pediatric rheumatologists from the Prevention and Treatment of Infections Working Group of the Spanish Society of Pediatric Rheumatology. Several recommendations were generated. A consensus procedure was implemented via a Delphi process that was extended to members of the Spanish Society of Pediatric Rheumatology and the Vaccine Advisory Committee of the Spanish Association of Pediatrics. Participants produced a score ranging from 0 (completely disagree) to 10 (completely agree). Agreement was considered to have been reached if at least 70% of participants voted ≥ 7. The literature review included more than 400 articles. Overall, 63 recommendations were generated (23 on infection prophylaxis) and voted by 59 pediatric rheumatologists and other pediatric specialists, all of whom achieved the pre-established level of agreement. The recommendations on prophylaxis of infection cover vaccination and prophylaxis against varicella zoster virus, tuberculosis, Pneumocystis jiroveccii, and invasive fungal infections in pediatric patients with immune-mediated rheumatic diseases receiving/scheduled to receive immunosuppressive therapy.
Conclusion: Based on current evidence and a Delphi process, we provided consensus and updated recommendations on prophylaxis and treatment of infections to guide those caring for pediatric rheumatology patients.Funding for open access charge: Universidad de Málaga/CBU
Correction to: Position statement of the Spanish society of pediatric rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: part 1 (screening)
CRUE-CSICSpringer NatureFunding agency CRUE-CSIC Springer Nature PfizerUniversidad de Malaga/CBUA3.860 JCR (2021) Q1, 28/130 Pediatrics0.806 SJR (2021) Q1, 65/319 Pediatrics, Perinatology and Child HealthNo data IDR 2021UE
Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening)
Abstract
This study provides practical recommendations on infection screening in pediatric patients with immune-mediated rheumatic
diseases and immunosuppressive therapies. For this reason, a qualitative approach was applied. A narrative literature review
was performed via Medline. Primary searches were conducted using Mesh and free texts to identify articles that analyzed
data on infections and vaccinations in pediatric patients with immune-mediated rheumatic diseases and immunosuppressive
therapies. The results were presented and discussed in a nominal group meeting, comprising a committee of 12 pediatric
rheumatologists from the infections prevention and treatment working group of the Spanish Society of Pediatric Rheuma tology. Several recommendations were generated. A consensus procedure was implemented via a Delphi process that was
extended to members of the Spanish Society of Pediatric Rheumatology and Vaccine Advisory Committee of the Spanish
Association of Pediatrics. Participants to the process produced a score ranging from 0=totally disagree to 10=totally agree.
Agreement was considered if at least 70% of participants voted≥7. The literature review included more than 400 articles.
Overall, 63 recommendations were generated (21 on infection screening) voted by 59 pediatric rheumatologists and other
pediatric specialists, all of them achieving the pre-established agreement level. The recommendations on screening cover all
the procedures (serology, assessment of risk factors, and other clinical activities) connected with the screening for infections
including tuberculosis; hepatitis A, B, and C viruses; measles; mumps; rubella; diphtheria; and other infections.
Conclusion: Screening for infections is an essential part of risk management in pediatric patients with immune-mediated
rheumatic diseases and immunosuppressive therapies.Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This project was partially funded by
an unrestricted grant of Pfzer. Pfzer did not take part in the design, development of the project, or in the manuscript. SERPE also provided funds to the project. Funding for open access charge: Universidad de Málaga / CBU